Vorreuther R, Hake R, Borchmann P, Lukowsky S, Thiele J, Engelmann U
Department of Urology, University of Cologne, Germany.
Urol Int. 1997;59(2):88-94. doi: 10.1159/000283032.
We present a retrospective study using four different immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections from 104 selected cases with primary superficial transitional cell carcinomas of the bladder (59 cases pTa, 45 cases pT1, 40 cases G1, 64 cases G2). 53 of the 104 patients experienced recurrence of their bladder lesion, while 51 remained free of tumor. The distribution of staging, grading and multifocality was comparable in both groups of patients. Overall, the tumors that recurred had a significantly higher proportion of labeled cells for PCNA (p < or = 0.0001), Ki-67 (p < or = 0.006) and 486p (p < or = 0.0001). The latter antigen proved to be the most reliable marker. A less significant difference in staining pattern was found for p53 (p < or = 0.01). Evaluating the predictive value of the various antibodies separately for the groups with G1 vs. G2 carcinomas and pTa vs. pT1 tumors revealed a lower significance for all antibodies. The technique of immunostaining on paraffin sections facilitates further retrospective studies on archival material. These markers may provide additional information about the probability of recurrence of superficial bladder tumors. But at the moment they should only be utilized in selected cases.
我们进行了一项回顾性研究,对104例经挑选的原发性膀胱浅表性移行细胞癌石蜡切片使用了四种不同的免疫组织化学标记物(增殖细胞核抗原、Ki-67、486p和p53)(59例pTa期,45例pT1期,40例G1级,64例G2级)。104例患者中,53例膀胱病变复发,51例无肿瘤复发。两组患者在分期、分级和多灶性分布方面具有可比性。总体而言,复发肿瘤中增殖细胞核抗原(p≤0.0001)、Ki-67(p≤0.006)和486p(p≤0.0001)标记细胞的比例显著更高。后一种抗原被证明是最可靠的标记物。p53染色模式的差异较小(p≤0.01)。分别评估各种抗体对G1级与G2级癌以及pTa期与pT1期肿瘤患者组的预测价值,发现所有抗体的显著性均较低。石蜡切片免疫染色技术有助于对存档材料进行进一步的回顾性研究。这些标记物可能为浅表性膀胱肿瘤的复发概率提供额外信息。但目前它们仅应在特定病例中使用。